Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
World J Gastroenterol ; 30(13): 1911-1925, 2024 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-38659485

RESUMO

BACKGROUND: Liuweiwuling Tablet (LWWL) is a Chinese patent medicine approved for the treatment of chronic inflammation caused by hepatitis B virus (HBV) infection. Previous studies have indicated an anti-HBV effect of LWWL, specifically in terms of antigen inhibition, but the underlying mechanism remains unclear. AIM: To investigate the potential mechanism of action of LWWL against HBV. METHODS: In vitro experiments utilized three HBV-replicating and three non-HBV-replicating cell lines. The in vivo experiment involved a hydrodynamic injection-mediated mouse model with HBV replication. Transcriptomics and metabolomics were used to investigate the underlying mechanisms of action of LWWL. RESULTS: In HepG2.1403F cells, LWWL (0.8 mg/mL) exhibited inhibitory effects on HBV DNA, hepatitis B surface antigen and pregenomic RNA (pgRNA) at rates of 51.36%, 24.74% and 50.74%, respectively. The inhibition rates of LWWL (0.8 mg/mL) on pgRNA/covalently closed circular DNA in HepG2.1403F, HepG2.2.15 and HepG2.A64 cells were 47.78%, 39.51% and 46.74%, respectively. Integration of transcriptomics and metabolomics showed that the anti-HBV effect of LWWL was primarily linked to pathways related to apoptosis (PI3K-AKT, CASP8-CASP3 and P53 pathways). Apoptosis flow analysis revealed that the apoptosis rate in the LWWL-treated group was significantly higher than in the control group (CG) among HBV-replicating cell lines, including HepG2.2.15 (2.92% ± 1.01% vs 6.68% ± 2.04%, P < 0.05), HepG2.A64 (4.89% ± 1.28% vs 8.52% ± 0.50%, P < 0.05) and HepG2.1403F (3.76% ± 1.40% vs 7.57% ± 1.35%, P < 0.05) (CG vs LWWL-treated group). However, there were no significant differences in apoptosis rates between the non-HBV-replicating HepG2 cells (5.04% ± 0.74% vs 5.51% ± 1.57%, P > 0.05), L02 cells (5.49% ± 0.80% vs 5.48% ± 1.01%, P > 0.05) and LX2 cells (6.29% ± 1.54% vs 6.29% ± 0.88%, P > 0.05). TUNEL staining revealed a significantly higher apoptosis rate in the LWWL-treated group than in the CG in the HBV-replicating mouse model, while no noticeable difference in apoptosis rates between the two groups was observed in the non-HBV-replicating mouse model. CONCLUSION: Preliminary results suggest that LWWL exerts a potent inhibitory effect on wild-type and drug-resistant HBV, potentially involving selective regulation of apoptosis. These findings offer novel insights into the anti-HBV activities of LWWL and present a novel mechanism for the development of anti-HBV medications.


Assuntos
Antivirais , Apoptose , DNA Viral , Medicamentos de Ervas Chinesas , Vírus da Hepatite B , Comprimidos , Replicação Viral , Apoptose/efeitos dos fármacos , Animais , Humanos , Vírus da Hepatite B/efeitos dos fármacos , Medicamentos de Ervas Chinesas/farmacologia , Camundongos , Células Hep G2 , Antivirais/farmacologia , Replicação Viral/efeitos dos fármacos , Modelos Animais de Doenças , Antígenos de Superfície da Hepatite B/metabolismo , Masculino , Hepatite B/tratamento farmacológico , Hepatite B/virologia , RNA Viral/metabolismo , Fígado/efeitos dos fármacos , Fígado/patologia , Fígado/virologia
2.
Chemosphere ; 334: 138638, 2023 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-37100254

RESUMO

The synthesis of metal nanoparticles using green chemistry methods has gained significant attention in the field of landscape enhancement. Researchers have paid close attention to the development of very effective green chemistry approaches for the production of metal nanoparticles (NPs). The primary goal is to create an environmentally sustainable technique for generating NPs. At the nanoscale, ferro- and ferrimagnetic minerals such as magnetite exhibit superparamagnetic properties (Fe3O4). Magnetic nanoparticles (NPs) have received increased interest in nanoscience and nanotechnology due to their physiochemical properties, small particle size (1-100 nm), and low toxicity. Biological resources such as bacteria, algae, fungus, and plants have been used to manufacture affordable, energy-efficient, non-toxic, and ecologically acceptable metallic NPs. Despite the growing demand for Fe3O4 nanoparticles in a variety of applications, typical chemical production processes can produce hazardous byproducts and trash, resulting in significant environmental implications. The purpose of this study is to look at the ability of Allium sativum, a member of the Alliaceae family recognized for its culinary and medicinal benefits, to synthesize Fe3O4 NPs. Extracts of Allium sativum seeds and cloves include reducing sugars like glucose, which may be used as decreasing factors in the production of Fe3O4 NPs to reduce the requirement for hazardous chemicals and increase sustainability. The analytic procedures were carried out utilizing machine learning as support vector regression (SVR). Furthermore, because Allium sativum is widely accessible and biocompatible, it is a safe and cost-effective material for the manufacture of Fe3O4 NPs. Using the regression indices metrics of root mean square error (RMSE) and coefficient of determination (R2), the X-ray diffraction (XRD) study revealed the lighter, smoother spherical forms of NPs in the presence of aqueous garlic extract and 70.223 nm in its absence. The antifungal activity of Fe3O4 NPs against Candida albicans was investigated using a disc diffusion technique but exhibited no impact at doses of 200, 400, and 600 ppm. This characterization of the nanoparticles helps in understanding their physical properties and provides insights into their potential applications in landscape enhancement.


Assuntos
Alho , Nanopartículas Metálicas , Nanopartículas Metálicas/toxicidade , Nanopartículas Metálicas/química , Óxido Ferroso-Férrico , Antioxidantes/química , Antifúngicos , Química Verde/métodos , Extratos Vegetais/química
3.
Toxicol Appl Pharmacol ; 454: 116215, 2022 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-36067808

RESUMO

Breast cancer is a fatal cancer with the highest mortality in female. New strategies for anti-breast cancer are still urgently needed. Catalpol, an iridoid glycoside extracted from the traditional Chinese medicinal plant Rehmannia glutinosa, has shown anticancer efficacy in various cancer cells. However, its effect on breast cancer remains unclear. In this study, we aim to investigate the anti-breast cancer activity of catalpol and elucidate its underlying mechanism. Cell counting kit-8 (CCK-8) and morphology change showed that catalpol could inhibit the proliferation and viability of MCF-7 cells. Catalpol administration reduced the tumor volume in xenograft model. Catalpol induced apoptosis in MCF-7 cells confirmed by Hoechst 33342 staining and Annexin V-FITC/PI double staining. In vivo, catalpol also induced apoptosis as seen from the increased level of terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) in tumor. According to JC-1 and Dichlorodi-hydrofluorescein Diacetate (DCFH-DA) staining, loss of mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) generation was found in MCF-7 cells treated with catalpol. Furthermore, catalpol also increased the level of cytoplasmic cytochrome c and activity of caspase-3 in MCF-7 cells. Likewise, histopathological and immunohistochemical (IHC) assay also found that catalpol enhanced the levels of cytochrome c and caspase-3 in breast cancer tissues. Ultimately, acetylation, 2-hydroxyisobutyrylation and lactylation were dramatically increased, whereas succinylation, malonylation and phosphorylation were markedly decreased in the breast cancer tumor treated with catalpol. Taken together, catalpol inhibited breast cancer in vitro and in vivo through induction of apoptosis via mitochondria apoptosis pathway and regulation of protein post-translational modifications (PTMs). Thus, it can be considered as an excellent candidate compound for treatment of breast cancer.


Assuntos
Neoplasias da Mama , Citocromos c , Apoptose , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/metabolismo , Caspase 3/metabolismo , Citocromos c/metabolismo , Feminino , Humanos , Glucosídeos Iridoides/farmacologia , Glucosídeos Iridoides/uso terapêutico , Mitocôndrias , Processamento de Proteína Pós-Traducional , Espécies Reativas de Oxigênio/metabolismo
4.
Digital Chinese Medicine ; (4): 68-74, 2022.
Artigo em Inglês | WPRIM | ID: wpr-974085

RESUMO

@#Objective To explore the transitive regularity of holistic constituents from the crude slices of the medicinal raw materials (MCS) to the formula granules (FG), fufang decoction (FD), and finally, the concentrated pills (CP) of Liuwei Dihuang Fufang (六味地黄复方, LWDHF). Methods Samples for MCS, FG, FD, and CP of LWDHF were obtained, and a fingerprint database was established using high-performance liquid chromatography (HPLC), by separating the samples in an XB-C18 column and analyzing the transitive regularity of components using the total quantum statistical moment (TQSM), including total quantum zero moment (AUCT), total quantum first moment (MRTT), total quantum second moment (VRTT), and its similarity approach. The AUCT, MRTT, and VRTT were calculated based on the representative HPLC chromatograms of FG, FD, and CP of LWDHF. Results AUCT of FG, FD, and CP of LWDHF was 71 804, 46 553, and 144 646 µV·s, respectively; MRTT was 14.43, 14.54, and 18.85 min, respectively; and VRTT was 106.98, 112.84, and 269.12 min2, respectively. Comparing the similarity of FG/FD, FG/CP and FD/CP of LWDHF, the TQSM similarity values were 98.66%, 76.62%, and 75.37%, respectively, whereas the traditional similarity evaluation values were 98.68%, 85.43%, and 85.60%, respectively. Conclusion The results perform little distinction in the total composition between FG and FD, whereas some distinction existed between FD and CP. Experimental evidence, therefore indicates that FG could be used as the alternative of MCS in clinical applications.

5.
Zhongguo Zhong Yao Za Zhi ; 46(2): 340-346, 2021 Jan.
Artigo em Chinês | MEDLINE | ID: mdl-33645120

RESUMO

With the emergence of drug resistance in Western medicine, the repeated administration of clinical first-line drugs becomes more severe. There are many factors leading to multidrug resistance(MDR), so it is very difficult to solve the problem. Since traditional Chinese medicine(TCM) has been used in the field of MDR in recent years, the research on the transporter-associated drug resistance and intervention of TCM has gradually become a hot spot. Therefore, in order to further explore the relationships among drug resistance, transporters, and TCM intervention, we review the relevant research progress in recent years and comb the achievements and limitations of this research at present. In the end, we put forward the research direction of changing body's ADME through the host's transporters and gastrointestinal flora, which provides new ideas for future research.


Assuntos
Medicamentos de Ervas Chinesas , Medicina Tradicional Chinesa , Resistência a Múltiplos Medicamentos , Proteínas de Membrana Transportadoras/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA